Sanctuary Advisors LLC Sells 178,407 Shares of Kenvue Inc. $KVUE

Sanctuary Advisors LLC trimmed its position in Kenvue Inc. (NYSE:KVUE) by 39.5% during the fourth quarter, Holdings Channel reports. The firm owned 273,035 shares of the company’s stock after selling 178,407 shares during the quarter. Sanctuary Advisors LLC’s holdings in Kenvue were worth $4,710,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of KVUE. Salomon & Ludwin LLC bought a new stake in shares of Kenvue in the 3rd quarter valued at about $25,000. NBT Bank N A NY raised its holdings in Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after acquiring an additional 1,006 shares during the period. Cornerstone Planning Group LLC raised its holdings in Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after acquiring an additional 1,361 shares during the period. Golden State Wealth Management LLC raised its holdings in Kenvue by 150.1% in the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after acquiring an additional 1,190 shares during the period. Finally, New England Capital Financial Advisors LLC raised its holdings in Kenvue by 81.4% in the 3rd quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock valued at $42,000 after acquiring an additional 1,150 shares during the period. 97.64% of the stock is owned by institutional investors.

Kenvue Stock Down 1.9%

Shares of KVUE opened at $17.21 on Thursday. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17. The firm’s 50 day moving average is $17.75 and its 200-day moving average is $17.17. The stock has a market capitalization of $33.03 billion, a PE ratio of 22.34, a P/E/G ratio of 3.98 and a beta of 0.61. The company has a current ratio of 0.96, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last announced its earnings results on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.22 by $0.05. Kenvue had a net margin of 9.72% and a return on equity of 19.72%. The company had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $3.68 billion. During the same period last year, the firm earned $0.26 earnings per share. The business’s revenue for the quarter was up 3.2% on a year-over-year basis. Equities research analysts forecast that Kenvue Inc. will post 1.1 EPS for the current year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th will be given a dividend of $0.2075 per share. The ex-dividend date is Wednesday, May 13th. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. Kenvue’s dividend payout ratio (DPR) is currently 107.79%.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a report on Wednesday, April 8th. Argus raised shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Jefferies Financial Group cut shares of Kenvue from a “buy” rating to a “hold” rating and lowered their price target for the company from $23.00 to $18.00 in a report on Friday, January 30th. Citigroup lowered their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Finally, Canaccord Genuity Group increased their price target on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. Three research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $19.33.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.